Filing Details

Accession Number:
0001225208-25-002992
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-05 16:16:17
Reporting Period:
2025-03-03
Filing Date:
2025-03-05
Accepted Time:
2025-03-05 16:16:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2013518 Emily Woodworth 300 Boston Scientific Way
Marlborough MA 01752-1234
Svp, Global Controller And Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-03 5,949 $37.50 8,063 No 4 M Direct
Common Stock Disposition 2025-03-03 7,149 $104.97 914 No 4 S Direct
Common Stock Disposition 2025-03-04 482 $104.63 432 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2025-03-03 5,949 $0.00 5,949 $37.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,383 2031-02-17 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.